Brief: Ultimovacs Says Topline Results Are Expected In First Half Of 2025
Aug 5 (Reuters) - Ultimovacs ASA ULTI.OL :
* ULTIMOVACS - TOPLINE RESULTS ARE EXPECTED IN FIRST HALF OF
2025
WELL WITHIN CURRENT FINANCIAL RUNWAY WHICH REACHES TO Q4 OF 2025
* ULTIMOVACS ASA - STUDY DID NOT MEET ITS PRIMARY AND
SECONDARY
ENDPOINTS.
Source text for Eikon: ID:nGNE3Kz2St
Further company coverage: ULTI.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant